Opinion of the Scientific Panel on food additives, flavourings, processing aids and materials in contact with food (AFC) related to Calcium L-Methylfolate

EFSA Journal

Volumn 2, Issue 11, 2004, Pages

[No Author Info available]

Author keywords

Calcium L 5 methyltetrahydrofolate; CAS Registry Numer 129025 21 4 and CAS Registry Number 151533 22 1; foods for particular nutritional uses (FPNUs); L 5 MTHF Ca

Indexed keywords

EID: 85078378546     PISSN: None     EISSN: 18314732     Source Type: Journal    
DOI: 10.2903/j.efsa.2004.135     Document Type: Article

References (68)

1. Ashfield-Watt P.A., Pullin C.H., Whiting J.M., Clark Z.E., Moat st. J., Newcombe R.G., Burr M.L., Lewis M.J., Powers H.J. and McDowell F.W. (2002). Methylenetetrahydrofolate reductase 677C→T genotype modulates homocysteine response to a folate-rich diet or a low-dose folic acid supplement: a randomised controlled trial. Am. J. Clin. Nutr. 76: 180–186.
2. Baik H.W. and Russell R.M. (1999). Vitamin B12 deficiency in the elderly. Annu. Rev. Nutr. 19: 357–377.
3. Barford P.A. and Blair J.A. (1975). Novel urinary metabolites of folic acid in the rat. Chem. Biol. Pteridines: 413–427.
4. Biodar (2000a). Microencapsulated Ca-Mefolinate Project. Final Report. Unpublished study of Bio Dar Ltd., Yavne (Israel).
5. Biodar (2000b). Microencapsulated Ca-mefolinate project. Development Report (December 2000). Unpublished study report of Bio Dar Ltd., Yavne (Israel).
6. Biodar (2001a). Microencapsulated Ca-Mefolinate Project. Development Report (January 2001). Unpublished study report of Bio Dar Ltd., Yavne (Israel).
7. Biodar (2001b). Microencapsulation of Ca-MTHF. Progress Report (March 2001). Unpublished study report of Bio Dar Ltd., Yavne (Israel).
8. Blair J.A., Pearson A.J. and Robb A.J. (1975). Autoxidation of 5-Methyl-5, 6,7,8-tetrahydrofolic acid. J.C.S. Perkin II, p. 18–21.
9. Borzelleca J.F., Glinsmann W.H. and Gregory J.F. (1999). Use of L-5-methyltetrahydrofolate in conventional foods and dietary supplements. Expert Panel Report. Unpublished report prepared for Merck KgaA.
10. Bostom A.G., Shemin D., Bagley P., Massy Z.A., Zanabli A., Christopher K., Spiegel P., Jacques P.F., Dworki L., and Selhub J. (2000). Controlled comparison of L-5-methyltetra-hydrofolate versus folic acid for the tratment of hyperhomocysteinemia in hemodialysis patients. Circulation 101: 2829–2832.
11. Clarke R. (1998). Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. BMJ 316: 894–898.
12. D'Angelo A., Mazzola G., Crippa L., Fermo I. and D'Angelo S.V. (1997). Hyperhomocysteinemia and venous thromboembolic disease. Rev. Haematologica 82: 211–219.
13. Day B.P.F. and Gregory J.F. (1983). Thermal stability of folic acid and 5-methyltetrahydrofolic acid in liquid model food systems. J. Food Sci. 48: 581–599.
14. De Bree A., Verschuren W.M.M., Bjorke-Monsen A.-L., van der Put N.M.J., Heil S.G., Trijbels F.J.M. and Blom H.J. (2003). Effect of the methylenetetrahydrofolate reductase 677C→T mutation on the relations among folate intake and plasma folate and homocysteine concentrations in a general population sample. Am. J. Clin. Nutr. 77: 687–693.
15. Duell P.B. and Malinow M.R. (1997). Homocysteine: an important risk factor for atherosclerose vascular disease. Current Opinion in Lipidology 8: 28–34.
16. Fohr I.P., Prinz-Langenohl R., Brönstrup A., Bohlmann A.M., Nau H., Berthold H.K. and Pietrzik K. (2002). 5,10-Methylenetetragydrofolate reductase genotype determines the plasma homocysteine-lowering effect of supplementation with 5-methyltetrahydrofolate or folic acid in healthy young women. Am. J. Clin. Nutr. 75: 275–282.
17. Godfrey P.S.A., Toone B.K., Carney M.W.P., Flynn T.G., Bottiglieri T., Laundy M., Chanarin I. and Reynolds E.H. (1990). Enhancement of recovery from psychiatric illness by methylfolate. Lancet 336: 392–395.
18. Gregory J.F. (1989). Chemical and nutritional aspects of folate research: Analytical procedures, methods of folate synthesis, stability and bioavailability of dietary folates. Advances in Food and Nutrition Research 33: 1–101.
19. Gregory J.F. (1996). Vitamins. Food Chemistry, 3rd ed. (O.R. Fennema. ed.), M. Dekker, p. 531–532, 590–599, 610-616.
20. Gutstein S., Bernstein L.H., Levy L. and Wagner G. (1973). Failure of response to N5-methyltetrahydrofolate in combined folate and vitamin B12 deficiency. Evidence in support of the “folate trap” hypothesis. Digest. Dis. 18 (2): 142–146.
21. Hamann H.-J., Luetkemeier H., Knuppe C. and Millar P.M. (2001). Calcium-L-Mefolinate (L-MTHF): 13-week oral toxicity (gavage) study in Wistar rats. RCC Project 758316. Unpublished study report of RCC Ltd., Itingen (Switzerland) for Merck KgaA, Darmstadt (Germany). (2 Volumes and 1 Report Amendment).
22. Hasselwander O., Hönlein W., Schweillert L. and Krömer K. (2000). 5-Methyltetrahydrofolate – the active form of folic acid. Functional Foods 2000, Conference Proceedings, p. 48–59.
23. Heusener A. and Eberstein M. (1998a). Calcium-L-Mefolinat - Acute toxicity study in rats after oral administration (ATC method). Unpublished study report for Eprova AG, Schaffhausen (Switzerland).
24. Heusener A. and Eberstein M. (1998b). Calcium-D/L-Mefolinat - Acute toxicity study in rats after oral administration (ATC method). Unpublished study report for Eprova AG, Schaffhausen (Switzerland).
25. Heusener A. and Eberstein M. (1998c). Calcium-D-Mefolinat - Acute toxicity study in rats after oral administration (ATC method). Unpublished study report for Eprova AG, Schaffhausen (Switzerland).
26. Heusener A. and Eberstein M. (1998b). Calcium-L-Mefox - Acute toxicity study in rats after oral administration (ATC method). Unpublished study report for Eprova AG, Schaffhausen (Switzerland).
27. Heusener A. and Eberstein M. (1998c). Calcium-L-MTHPA - Acute toxicity study in rats after oral administration (ATC method). Unpublished study report for Eprova AG, Schaffhausen (Switzerland).
28. Howe J. (2002). Art. 100461 (Calcium-L-Mefolinate): Measurement of unscheduled DNA synthesis in rat liver using an in vivo/in vitro procedure. Unpublished study report of Covance Laboratories Ltd., North Yorkshire (U.K.) for Merck KgaA, Darmstadt (Germany).
29. Jones M.L. and Nixon P.F. (2002). Tetrahydrofolates are greatly stabilized by binding to bovine milk folate-binding protein. J. Nutr. 132: 2690–2694.
30. Jongejan J.A., Mager H.I.X. and Berends W. (1979). Antoxidation of 5-alkyl-tetrahydropteridines the oxidation product of 5-methyl-THF. The Chemistry and Biology of Pteridines (Kisliuk R. ed.), Elsevier North Holland, p. 241–246.
31. Kariluoto S., Vahteristo L.T., Finglas P.M., De Meer K., Nau H. and Kehlenbach U. (2002). Population estimates of folate intake from food analyses. Am. J. Clin. Nutr. 76 (3): 689–691.
32. Kennelly J.C., Blair J.A. and Pheasant A.E. (1982). The metabolism of 5-methyltetrahydropteroyl-L-glutamic acid and its oxidation products in the rat. Biochem. J. 206: 373–378.
33. Konings E.J.M. (1999). A validated liquid chromatographic method for the determination of folates in vegetables, milk powder, liver and flour. J. AOAC Int. 82 (1): 119–127.
34. Konings E.J.M., Roomaans H.H.S., Dorant E., Goldbohm R.A., Saris W.H.M., and Van den Brandt P.A. (2001). Folate intake of the dutch population according to newly established liquid chromatography data for foods. Am. J. Clin. Nutr. 73: 765–76.
35. Lamers Y., Prinz-Langenhohl R., Moser R. and Pietrzik K. (2003). [6S]-5-methyltetrahydrofolate is as effective as folic acid in lowering plasma total homocysteine. J. Inherit. Metab. Dis. 26 (Suppl. 1), p. 10.
36. Leichter J., Switzer V.P. and Landymore A.F. (1978). Effect of cooking on folate content of vegetables. Nutr. Rep. Int. 18: 475–479.
37. Loehrer F.M.T., Angst Ch.P., Haefeli W.E., Jordan P.P., Ritz R. and Fowler B. (1996). Low whole-blood S-adenosyl-methionine and correlation between 5-methyltetrahydrofolate and homocysteine in coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 16: 727–733.
38. Meleady R., Ueland P.M., Blom H., Whitehead A.S., Refsum H., Daly L.E., Vollset St.E., Donohue C., Giesendorf B., Graham I.M., Ulvik A., Zhang Y., Monsen A.-L.B. and the EC concerted action projects (2003): Homocysteine and vascular disease. Am. J. Clin. Nutr. 77: 63–70.
39. Mnkeni A.P. and Beveridge T. (1983). Thermal destruction of 5-methyltetrahydrofolic acid in buffer and model food systems. J. Food Sci. 48: 595–599.
40. O'Broin J., Temperley I.J., Brown J.P. and Scott J.M. (1975). Nutritional stability of various naturally occurring monoglutamate derivatives of folic acid. Am. J. Clin. Nutr. 28: 438-444. Paine-Wilson B. and Chen T.-S. (1979). Thermal destruction of folacin: effect of pH and buffer ions. J. Food Sci. 44: 717–722.
41. Pawlosky R.J., Flanagan V.P. and Doherty R.F. (2003). A mass spectrometric validated high-performance liquid chromatography procedure for the determination of folates in foods. J. Agric. Food Chem. 51 (13): 3726–3730.
42. Perna A.F., Ingrosso D., De Santo N.G., Galetti P., Brunone M. and Zappia V. (1997). Metabolic consequences of folate-induced reduction of hyperhomocysteinemia in uremia. J. Am. Soc. Nephrol. 8: 1899–1905.
43. Prinz-Langenohl R., Brönstrup A., Thorand B., Hages M. and Pietrzik K. (1999). Availability of food folate in humans. J. Nutr. 129 (4): 913–916.
44. Prinz-Langenohl R., Lamers Y., Moser R. and Pietrzik K. (2003). Effect of folic acid preload on the bioequivalence of [6S]-5-methyltetrahydrofolate and folic acid in healthy volunteers. J. Inherit. Metab. Dis. 26 (Suppl. 1): 124.
45. Quéré I., Perneger T.V., Zittoun J., Bellet H., Gris J.-Ch. Daurès J.-P. Schved J.-F., Mercier E., Laroche J.-P. Dauzat M., Bounameaux H., Janbon C. and De Moerloose P. (2002). Red blood cell methylfolate and plasma homocysteine as risk factors for venous thromboembolism: a matched case-control study. Lancet 359: 747–752.
46. Rader J.I., Weaver C.M. and Angyal G. (1998). Use of a microbiological assay with tri-enzyme extraction for measurement of pre-fortification levels of folates in enriched cereal-grain products. Food Chem. 62 (4): 451–465.
47. Ratanasthien K., Blair J.A., Leeming R.J., Cooke W.T. and Melikian V. (1977). Serum folates in man. J. Clin. Path. 30: 438–448.
48. Rothenberg S.P. (1999). Increasing the dietary intake of folate: pros and cons. Seminars in Hematology 36: 65–74.
49. SCF (1993). Nutrient and energy intakes for the European Community. Reports of the Scientific Committee for Food, thirty-first series. europa.eu.int/comm/food/fs/sc/scf/out89.pdf.
50. SCF (2000). Opinion of the Scientific Committee on Food on the tolerable upper intake level of folate. SCF/CS/NUT/UPPLEV/ 18 Final. europa.eu.int/comm/food/fs/sc/scf/out80e_en.pdf.
51. SCF (2003). Opinion of the Scientific Committee on Food on the tolerable upper intake level of calcium. SCF/CS/NUT/UPPLEV/64 Final. europa.eu.int/comm/food/fs/sc/scf/out194_en.pdf.
52. Schubert Ch. and Jacobs M. (2003). Art. 100461 (Metafolin)-Prenatal developmental toxicity study after oral administration to rats. Unpublished study report of Merck KgaA, Darmstadt, Germany for Merck Eprova AG, Schaffhausen, Switzerland.
53. Scott J.M. and Weir D.G. (1981). The methyl folate trap. Lancet 15: 337–340.
54. Selhub J., Gregory J.F. and Glinsmann W. (2001). Nutritional functions and safety of consumption of L-5-methyltetrahydrofolate the naturally occurring predominant form of dietary folate and its vital role in folate physiology. Unpublished review of the scientific literature prepared for Merck KgaA, Darmstadt (Germany).
55. Thomas P.M., Flanagan V.P. and Pawlosky R.J. (2003). Determination of 5-methyltetrahydrofolic acid and folic acid in citrus juices using stable isotope dilution-mass spectrometry. J. Agric. Food Chem. 51 (5): 1293–1296.
56. Utesch D. (1999a). Calcium-L-Mefolinat - Bacterial mutagenicity assay, Salmonella typhimurium and Escherichia coli. Unpublished study report for, Eprova AG, Schaffhausen (Switzerland).
57. Utesch D. (1999b). Calcium-D/L-Mefolinat - Bacterial mutagenicity assay, Salmonella typhimurium and Escherichia coli. Unpublished study report for Eprova AG, Schaffhausen (Switzerland).
58. Utesch D. (1999c). Calcium-D-Mefolinat - Bacterial mutagenicity assay, Salmonella typhimurium and Escherichia coli. Unpublished study report for Eprova AG, Schaffhausen (Switzerland).
59. Utesch D. (1999d). Calcium-L-Mefox - Bacterial mutagenicity assay, Salmonella typhimurium and Escherichia coli. Unpublished study report for Eprova AG, Schaffhausen (Switzerland).
60. Utesch D. (1999e). Calcium-L-MTHPA - Bacterial mutagenicity assay, Salmonella typhimurium and Escherichia coli. Unpublished study report for Eprova AG, Schaffhausen (Switzerland).
61. Utesch D. (2000a). Calcium-L-Mefolinat - In vitro mammalian cell gene mutation test (L5178Y/TK±). Unpublished study report for Merck KGaA, Darmstadt (Germany).
62. Utesch D. (2000b). Calcium-L-Mefolinat - Micronucleus test in male rats after oral administration. Unpublished study report for Merck KGaA, Darmstadt (Germany).
63. Venn B.J., Green T.J., Moser R., McKenzie J.E., Skeaff C.M. and Mann J. (2002). Increases in blood folate indices are similar in women of childbearing age supplemented with [6S]-5-methyltetrahydrofolate and folic acid. J. Nutr. 132 (11): 3353–3355.
64. Venn B.J., Green T.J., Moser R. and Mann J.I. (2003). Comparison of the effect of low-dose supplementation with L-5-methyltetrahydrofolate or folic acid on plasma homocysteine: a randomized placebo-controlled study. Am. J. Clin. Nutr. 77: 658–662.
65. Verwei M., Arkbage K., Havenaar R., Van den Berg H., Witthöft C. and Schaafsmaa G. (2003). Folic acid and 5-methyltetrahydrofolate in fortified milk are bioaccessible as determined in a dynamic in vitro gastrointestinal model. J. Nutr. 133: 2377–2383.
66. Viberg U., Jägerstad M., Öste R. and Sjöholm I. (1997). Thermal processing of 5-methyltetrahydrofolic acid in the UHT region in the presence of oxygen. Food Chem. 59 (3): 381–386.
67. Vollset St.E., Refsum H., Tverdal A., Nygard O., Nordrehaug J.E., and Ueland P.M. (2001). Plasma total homocysteine and cardiovascular and noncardiovascular mortality: the hordaland homocysteine study. Am. J. Clin. Nutr. 74: 130–136.
68. Whiteley J.M. and Russell A. (1981). Structural reassignment of the peroxide oxidation product of 5-methyl-5, 6,7,8-tetrahydrofolate. Biochem. Biophys. Res. Commun. 101 (4): 1259–1265.